Physician profile
Christopher T Stark
NPI 1316934813
$4,231.97
in general payments reported to CMS, 2019-2025
15 companies · $2,069 in 2025
The $2,069 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,568 · 2020: $23.50 · 2021: $105 · 2022: $24.98 · 2023: $99.97 · 2024: $342 · 2025: $2,069.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,586 · Food and Beverage: $925.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,585.83 |
| Food and Beverage | $924.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,694.88 | 2019-2025 | |
| Music City Medical Technologies, LLC | $967.25 | 2024-2025 | |
| Alpha Orthopedic Systems | $952.23 | 2019-2023 | |
| Sirtex Medical INC | $257.25 | 2024 | Sir-Spheres Microspheres |
| Stryker Corporation | $94.56 | 2024-2025 | Makoplasty, Reunion, Triathlon |
| Zimmer Biomet Holdings, INC. | $51.94 | 2021 | |
| Smith+Nephew, INC. | $48.48 | 2020-2022 | |
| Convatec INC. | $41.82 | 2024 | |
| Pacira Therapeutics, INC. | $34.06 | 2019-2021 | |
| Cms Imaging, INC. | $18.82 | 2021 | |
| Avanos Medical | $17.05 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $14.66 | 2025 | |
| Bioventus LLC | $14.32 | 2021 | |
| Sanofi-Aventis U.S. LLC | $12.70 | 2019 | |
| Ferring Pharmaceuticals INC. | $11.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Stark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.